Synlait Milk (ASX: SM1) has completed the NZ$307 million sale of its North Island assets to Abbott, using NZ$200 million of the proceeds to repay bank facilities and reduce its committed debt by half.
The transaction included the Pōkeno manufacturing facility, associated inventory, and specific Auckland leasehold blending/canning and warehouse sites.
Gross proceeds received overnight amounted to approximately NZ$283.1 million.
Approximately NZ$14 million of the total proceeds is being held back, which will be progressively released if no post-completion claims arise.
Debt Reduction Achieved
A substantial portion of the sale proceeds, NZ$200 million, has been allocated to repay bank facilities.
This repayment has effectively halved Synlait’s committed bank facilities, reducing them from NZ$400 million to NZ$200 million.
The company expects ongoing refinancing efforts for its remaining facilities, which are set to mature by 30 June 2026.
Additionally, Synlait has a NZ$130 million shareholder loan from Bright Dairy maturing on 12 July 2026.
HY26 Financial Headwinds
This strategic asset sale follows a challenging period for Synlait.
For the six months ended 31 January 2026, the company reported a net loss of NZ$80.6 million, representing a significant deterioration from the prior comparable period.
Revenue from continuing operations remained flat at NZ$777.6 million.
Due to operational constraints and unfavourable market conditions, the Board withdrew its financial guidance for the remainder of FY26.
Recovery Roadmap and Risks
Synlait's management is activating a "Stabilise, Simplify, Scale" recovery roadmap.
This plan focuses on uplifting operational stability and creating greater commercial optionality, particularly for its South Island assets.
Despite the balance sheet reset from the asset sale, the company still faces residual execution and funding risks.
Further, enhanced ARA testing is expected to extend release times, impacting working capital.
Management acknowledges that the path to profitability recovery is expected to take time.
Bottom Line
The completion of the North Island asset sale to Abbott marks a critical milestone for Synlait Milk in reducing its debt burden and simplifying its business.
However, the company faces ongoing challenges in restoring profitability and operational stability, with significant risks related to refinancing and market conditions.
